What is IR-Med Inc. (IRME) stock price today?

IR-Med Inc. (IRME) is currently trading at $0.00.

What is IRME P/E ratio?

IR-Med Inc.'s P/E ratio is -0.05. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is IRME return on equity (ROE)?

IR-Med Inc.'s return on equity (ROE) is 263.69%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is IR-Med Inc.'s market cap?

IR-Med Inc. has a market capitalization of $84963.

OTC · Medical - Devices

IR-Med Inc. (IRME) Stock

$0.00 OTC: IRME Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$84963
P/E Ratio	-0.05
P/B Ratio	-0.13
P/S Ratio	0.00
EPS (TTM)	$-0.03
52-Week High	$0.05
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	263.69%
ROA	-842.29%
ROCE	89.98%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.40
Current Ratio	0.12

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-1.0M	$-4.0M	$-5.0M	$-5.0M	$-2.0M
Net Profit	$-1.0M	$-4.0M	$-9.0M	$-5.0M	$-2.0M
EPS	$-0.03	$-0.06	$-0.14	$-0.07	$-0.03
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$2.0M	$3.0M	$3.0M	$1.0M	$0
Total Liabilities	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Cash	$2.0M	$3.0M	$3.0M	$1.0M	$0
Borrowings	$0	$0	$0	$0	$0

Latest News

IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan GlobeNewswire · Sep 16, 2026

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$0	$-2.0M	$-3.0M	$-3.0M	$-1.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$1.0M	$0
Net Cash Flow	$2.0M	$1.0M	$0	$-2.0M	$-1.0M
Free Cash Flow	$0	$-3.0M	$-3.0M	$-3.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.51
FCF Yield	-213.03%
Quick Ratio	0.12
Interest Coverage	-0.58
Return 1Y	-94.50%
Return 3Y	-99.91%
Return 5Y	—

Ownership

Insiders Held44.36%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
LLBOLifeline Biotechnologies, Inc.	$0.00	—	-37.30	$2.17M	0.00%
LMLLFPharmadrug Inc.	$0.01	+17.46%	-2.33	$993184	0.00%
PLLWFPolarean Imaging plc	$0.01	+0.00%	-0.12	$7.97M	0.00%
RMSLREMSleep Holdings, Inc.	$0.00	—	0.00	$2.71M	0.00%
RVVTFRevive Therapeutics Ltd.	$0.02	-2.56%	-1.09	$8.28M	0.00%

About IR-Med Inc.

IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.

IR-Med Inc. (IRME) stock trades at $0.00 with a market capitalization of $84963. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.05, reflecting a net loss over the last twelve months, a negative price-to-book of -0.13, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 100.0% below its 52-week high.

On profitability, IR-Med Inc. generates a return on equity (ROE) of 263.69% (not meaningful, as shareholders' equity is negative), return on capital employed of 89.98%.

Official website: www.ir-medical.com